FDA Inspection 1066186 — Octapharma Plasma, Inc.
The FDA completed an inspection of Octapharma Plasma, Inc. on Sep 7, 2018 in Evansville, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 7, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Evansville, IN (United States)